These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 487944)

  • 1. [Efficacy and tolerability of cefazedone in infectious skin diseases; determination of serum and tissue concentrations (author's transl)].
    Schneider C; Koch E
    Derm Beruf Umwelt; 1979; 27(3):75-7. PubMed ID: 487944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefazedone in infectious diseases in gynecology. Clinical tests on efficacy and tolerance].
    von Kobyletzki D; Primavesi CA; Koch E
    Fortschr Med; 1979 Feb; 97(5):214-8. PubMed ID: 372073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diffusion of cefazedone into heart muscle, prostatic and skin tissue and into bile].
    Adam D; Hofstetter AG; Reichart B; Schneider C; Wolff H; Koch E
    Arzneimittelforschung; 1979; 29(12):1901-6. PubMed ID: 546431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. I. Tolerance in comparison with cefazolin.
    Ungethüm W; Leopoid G
    Arzneimittelforschung; 1979; 29(2a):435-6. PubMed ID: 582721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of cefazedone.
    Koch E; Friese J; Debuch KE
    Arzneimittelforschung; 1979; 29(2a):456-60. PubMed ID: 582726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study on the tolerance of cefazedone.
    Züllich B; Sack K
    Arzneimittelforschung; 1979; 29(2a):453-6. PubMed ID: 582725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefazedone-results of a multicentre clinical test (author's transl)].
    Koch E; Wiemann H; Empl I
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):431-4. PubMed ID: 6769007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily cefazolin and probenecid for skin and soft tissue infections.
    Cox VC; Zed PJ
    Ann Pharmacother; 2004 Mar; 38(3):458-63. PubMed ID: 14970368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of a new semi-synthetic cephalosporin cephradine upon staphylococci and gonococci.
    Stringer HC
    N Z Med J; 1973 May; 77(492):298-301. PubMed ID: 4516083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS; Jones RN
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of cephradine to dermatoses by injection (author's transl)].
    Takahashi H; Kaneko O; Fukuda N
    Jpn J Antibiot; 1976 Nov; 29(11):955-7. PubMed ID: 1003678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penetration of cephaloridine and cephalothin into the cerebrospinal fluid-clinical study (author's transl)].
    Kano M; Ohta H; Kinjo T; Ito A
    No Shinkei Geka; 1975 Apr; 3(4):305-12. PubMed ID: 1239674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime treatment of skin and skin structure infections: a multicenter study.
    LeFrock JL; McCloskey RV
    Clin Ther; 1982; 5 Suppl A():19-25. PubMed ID: 6293714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.